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Abstract To investigate whether overexpression of human c-Src
leads to cell rounding in anchorage-dependent NIH3T3 fibro-
blasts, we have established c-Src-inducible cell lines using a lac
repressor^operator system. RN1 cells, which expressed c-Src at
a high level after induction, exhibited a spherical morphology and
ceased to grow in monolayer culture. RN1 cells, however,
exhibited neither focus-forming ability nor anchorage-independ-
ent growth potential with or without induction. Induced RN1 c-
Src was phosphorylated at Ser
75
, a previously reported spherical
cell-associated site, and at Tyr
419
. These data demonstrated for
the first time that highly elevated human c-Src tyrosine kinase
activity can cause NIH3T3 cells to have a spherical morphology
without loss of anchorage-dependent growth. The inducible cell
line should be useful to study the mechanism for cell rounding by
c-Src.
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1. Introduction
The cellular c-src gene product, c-Src, is a membrane-asso-
ciated 60 kDa tyrosine kinase, which is structurally homolo-
gous to the transforming product, v-Src. The normal cellular
function of c-Src is not fully understood, although v-Src de-
regulates cell growth [1,2]. High-level expression of c-Src in
terminally di¡erentiated cells such as neurons [3] and platelets
[4], suggests that its cellular activities are unrelated to growth
regulation.
Recent studies suggest that c-Src is involved in regulation of
cell morphology [5] and cell adhesion to a substratum [6]. c-
Src is activated during ¢broblast mitosis accompanied by
phosphorylation of serine and threonine in the amino terminal
regulatory domain of the protein [7,8]. The mitotic cells de-
crease the cell adhesion to a substratum and then round up.
We have previously found that a Ser
75
phosphorylation event
in human c-Src correlates with cell spherical morphology [9].
Human retinoblastoma Y79 cells, growing in a suspension of
spherical cells, express c-Src phosphorylated on Ser
75
through-
out the cell cycle. c-Src from ¢broblast-like and epithelial-like
cell lines adherent to substrata is phosphorylated on Ser
75
only during mitosis. Furthermore, v-src-transformed chicken
and rat embryo ¢broblasts display a spherical and refractile
morphology similar to mitotic cells [10], implying that these v-
src-induced e¡ects are caused by deregulation of the putative
normal function of cell rounding in c-Src.
To test whether human c-Src plays a role in cell rounding,
we overexpressed human c-Src in NIH3T3 ¢broblasts. We
induced the expression of human c-Src in NIH3T3 ¢broblasts
using the lac repressor and operator system. Induction of
high-level expression of c-Src with isopropyl-L-D-thiogalacto-
side (IPTG) changed spread and adherent ¢broblastic cells
into spherical cells and inhibited cell growth. We found that
these changes were dependent on high-level activity of human
c-Src tyrosine kinase and were accompanied by speci¢c phos-
phorylation of the Ser
75
in human c-Src.
2. Materials and methods
2.1. Materials
LacSwitch Inducible Mammalian Expression System was purchased
from Stratagene. Geneticin (G418) was from Life technologies. Hy-
gromycin B was from Sigma. Monoclonal anti-Src antibody 327 was
obtained from Oncogene Science. Monoclonal anti-phosphotyrosine
antibody 4G10 was from Upstate Biotechnology. Herbimycin A was
purchased from WAKO, Japan.
2.2. Cells
NIH3T3 cells were obtained from the Health Science Research
Resources Bank (Osaka) and cultured in DMEM plus 10% calf serum
at 37³C.
2.3. Transfection
A human c-src cDNA [9] was cloned into pOPI3 operator vector
(Stratagene). NIH3T3 cells (8U10
6
) were mixed on ice with 25 Wg of
p3PSS lac-repressor-expressing vector (Stratagene) and 30 Wg of
pOPI3-src, and then electroporated with a Bio-Rad Gene Pulser at
a setting of 1.2 kV and 25 WF. After 48 h, cells were cultured in
selective medium containing hygromycin B (200 Wg/ml) and G418
(500 Wg/ml). After 21^30 days, resistant colonies were selected and
expanded in selective medium. The stably transfected cells were in-
duced by the addition of IPTG (0.1^5 mM) to the media.
2.4. Immunoprecipitation
Cells were lysed with detergent lysis bu¡er [11] supplemented with
50 mM L-glycerophosphate, 25 mM NaF and 0.15 mM sodium or-
thovanadate. c-Src was immunoprecipitated with anti-Src antibody
from cell lysates and separated on SDS-10% PAGE as described [11].
2.5. Immunoblot analysis
c-Src levels were measured by immunoblot analysis as described
previously [11] except that colored bands were detected with a
420OE Scanner (Pharmacia). For tyrosine phosphorylation analysis
of cellular proteins, lysate proteins (20 Wg) were separated by 7.5%
SDS-PAGE, transferred to nitrocellulose, and probed with a 1:4000
dilution of anti-phosphotyrosine antibody. The ¢lters were treated
with a 1:1000 dilution of biotinylated goat anti-mouse IgG (Life
Technologies) and then with a 1:1000 dilution of tangerine-labeled
streptoavidin (Molecular Probes). Phosphorylated proteins were de-
tected with an FMBIO-100 Fluorescent Image Analyzer (TAKARA).
2.6. Kinase assays
Autophosphorylation and enolase phosphorylation were measured
by immune complex kinase assay and detected by BAS2000 (Fuji) as
described previously [11].
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2.7. Radiolabeling of cells
RN1 cells were cultured with or without IPTG treatment for 18 h
and were labeled with 1 mCi/ml [
32
P]orthophosphate (ICN) as de-
scribed previously [9] except that IPTG was included in the media
for the induced cells.
2.8. Phosphopeptide analyses
V8 protease and 2-dimensional tryptic phosphopeptide mappings
were performed as described previously [11]. Cyanogen bromide di-
gests [12] were analyzed on Tricine-SDS-PAGE (16.5% T/3% C) as
described [13]. Phosphoamino acid analysis was conducted as previ-
ously described [11].
3. Results
3.1. Human c-Src overexpression induces a spherical
morphology of NIH3T3 cells
We sought to test whether overexpression of human c-src
causes anchorage-dependent ¢broblasts to have a spherical
morphology. Fibroblasts require adhesion to substrata for
cell growth and survival [14]. If they are held detached and
rounded up, they cease growing. Accordingly, constitutive
overexpression of a gene enhancing cell rounding will inhibit
cell growth and survival, unless it induces transformation of
cells to exhibit anchorage independence of growth. Overex-
pression of chicken and human c-src does not induce the
transformation of mouse NIH3T3 ¢broblasts [15^17]. There-
fore, we have stably co-transfected NIH3T3 cells with a lac
operator vector containing human c-src cDNA and a lac
repressor-expressing vector to obtain c-Src-inducible cell
lines.
Immunoblotting analysis showed that isolated clonal cell
lines expressed various elevated levels of c-Src after induction
for 20 h with IPTG (Fig. 1A). The relative levels of c-Src from
RN1, RN2, RN3 and RN4 cell lines after induction were 63-,
37-, 33-, 12-fold, respectively, of that of the parent NIH3T3
cells. In the parent NIH3T3 cells and control vector trans-
fectants, IPTG did not induce the elevation of c-Src levels
(Fig. 1A). All four human c-Src-expressing cell lines produced
kinase-active c-Src, as judged from autophosphorylation assay
of the immunoprecipitated c-Src (Fig. 1A). Spherical cells,
part of which are detached from the substrata, appeared in
RN1 cells expressing the highest level of c-Src after IPTG
induction (Fig. 2A,B). A similar morphological change was
never observed in cell lines (RN2-RN4) expressing lower lev-
els of c-Src than RN1, or in the parent NIH3T3 cells (Fig.
2G,H).
3.2. Correlation between c-Src kinase activity level and cell
rounding in RN1 cells
To study the relationship of both c-Src and its kinase ac-
tivity level to morphological alteration in RN1 cells, we per-
formed immunoblotting and in vitro immune complex kinase
assay of the immunoprecipitated c-Src from these cells during
induction for 24 h with IPTG. Both levels of c-Src and its
kinase activity increased 5- and 50-fold, respectively, by 24 h
after initiation of the induction (Fig. 1B). c-Src levels were
nearly equal after induction for 20^72 h (data not shown).
A small number of spherical cells appeared after 10 h induc-
tion, which produced more than 70% of the level of c-Src after
24 h induction (Fig. 1B). The percentage of spherical cells
increased to about 60% of the total cells after 24 h induction.
Furthermore, 48 h after IPTG removal, the levels of c-Src and
its kinase activity decreased to about half the levels of the
continuously induced cells (Fig. 1B), and concomitantly,
spherical cells adhered to the substratum and spread to restore
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Fig. 1. (A) c-Src expression in transfected NIH3T3 cells. Human c-
Src was expressed in NIH3T3 cells using the LacSwitch Inducible
Mammalian Expression System. Cells were co-transfected with a
p3PSS repressor vector and a pOPI3-src vector, and clones resistant
to G418 and hygromycin B were isolated. The clonal cells at the
middle log phase were treated or untreated with 0.5 mM IPTG for
20 h and lysed. c-Src was immunoprecipitated from the cell lysates
(RN1-4 cells: 10 Wg of lysate protein; parent 3T3 cells and control
vector transfectants: 50 Wg of lysate protein). The immunoprecipi-
tates were subjected to anti-Src immunoblot analysis and autophos-
phorylation assay, respectively. c-Src expression level and rate of
the spherical cells were unchanged in the range between 0.1 and
5 mM IPTG. (B) c-Src expression level and morphology in RN1
cells. (Induction) RN1 cells were induced with IPTG for the indi-
cated times as described above. (Removal) RN1 cells induced for 24
h with IPTG were washed with PBS exhaustively and then cultured
for 48 h in the fresh medium from which IPTG was removed (+) or
not (3). (Herbimycin A) RN1 cells induced for 6 h were treated
with 0.05 Wg/ml herbimycin A (+) or DMSO containing no herbi-
mycin A (3) and then cultured continuously for 18 h with the in-
ducer included. These cells were lysed, and the immunoprecipitated
c-Src per 10 Wg of lysate protein was subjected to anti-Src immuno-
blot analysis and enolase phosphorylation assay, respectively. (C)
Tyrosine phosphorylation of cellular proteins in RN1 cells. Lysates
were prepared from cells treated (+) or untreated (3) with IPTG
for 24 h (induction), removal of IPTG (removal), or herbimycin A
(herbimycin) as described above. Lysate proteins were separated by
SDS-PAGE and then subjected to anti-phosphotyrosine immunoblot
analysis. White arrows show the position of molecular mass stand-
ards 205, 116, 67, and 45 kDa. Black arrows show Rf values corre-
sponding to molecular masses of 118, 77, 66, 63, and 42 kDa.
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the ¢broblastic morphology (Fig. 2C). In contrast, the con-
tinued induction for 48 h retained the spherical morphology
(Fig. 2D).
Next, we tested whether a Src kinase speci¢c inhibitor, her-
bimycin A [18], inhibits the change in RN1 cells. When her-
bimycin A was added to the culture after 6 h induction to a
¢nal concentration of 0.05 Wg/ml, the level of c-Src kinase
activity decreased to the one-third of that of the control cul-
ture after further induction for 18 h. Herbimycin A did not
change the c-Src level at this concentration (Fig. 1B). Spher-
ical cells were about 3-fold less than those in the culture with-
out herbimycin A (Fig. 2E,F).
Finally, we examined the pattern of tyrosine phosphoryla-
tion of cellular proteins by immunoblotting the cell lysates
with anti-phosphotyrosine antibody. Tyrosine phosphoryla-
tions of 118, 77, 66, 63 and 42 kDa proteins in RN1 cells
increased more than 4-fold after induction, suggesting that
the ¢ve proteins were phosphorylated directly or indirectly
by c-Src kinase (Fig. 1C). Moreover, these tyrosine phospho-
rylations were all reduced more than 3-fold and 6-fold, re-
spectively, by IPTG removal and herbimycin A treatment
(Fig. 1C). No change was detected in the parent 3T3 cells
after induction (Fig. 1C).
3.3. E¡ects of overexpressed c-Src on RN1 proliferation
To test whether RN1 cells after induction of human c-Src
retain an anchorage dependence of growth in monolayer cul-
ture such as parent 3T3 ¢broblasts, we assayed the e¡ects of
IPTG induction on cell growth of RN1 cells (Fig. 3). The
IPTG induction led to inhibition of RN1-cell proliferation
incidental to cell rounding (Fig. 2AFig. 3). The removal of
IPTG and the herbimycin A treatment restored RN1-cell pro-
liferation maintaining a ¢broblastic morphology (Fig.
2C,EFig. 3). Thus, c-Src-overexpressing RN1 cells exhibiting
decreased adhesion and a spherical morphology failed to in-
crease in cell number. RN1 cells in suspension, irrespective of
IPTG treatment, exhibited no colony formation in soft agar
and no growth potential in agar-coated dishes [14] (data not
shown). These results indicate that the RN1 cells have anchor-
age dependence.
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Fig. 2. Morphologies of RN1 cells with or without IPTG induction.
RN1 cells (A and B) and parent NIH3T3 cells (G and H) at the
middle log phases were treated (A and G) or untreated (B and H)
with IPTG for 24 h. The treated RN1 cells were washed and then
cultured for 48 h with (C) or without (D) removal of IPTG as de-
scribed in Fig. 1B. RN1 cells were treated (E) or untreated (F) with
herbimycin A as described in Fig. 1B. Magni¢cation: U117.
Fig. 3. E¡ects of IPTG induction on cell growth of RN1 cells. RN1
cells (2U10
5
cells) were seeded per 6 cm culture dish and cultured
for 2 days. The cultures were induced (b), uninduced (a), induced
for 24 h followed by removal of IPTG (O), or induced for 6 h fol-
lowed by herbimycin A treatment as described in Fig. 1B (R). The
attached and detached cells combined were counted in duplicate
dishes at the indicated times. Cell numbers were normalized to the
number of cells at the start of IPTG treatment (zero time point, as-
signed a value of 1).
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3.4. Comparison of phosphorylation status of RN1 c-Src with
or without IPTG induction
We examined the alteration of the phosphorylation status
of overexpressed c-Src from RN1 cells after induction by
phosphopeptide mapping and phosphoamino acid analysis.
Patterns of V8 mapping of in vivo phosphorylated RN1 c-
Src were unchanged irrespective of IPTG treatment (Fig. 4A).
The patterns were identical to that of normal c-Src [11]. The
tyrosine phosphorylation status of C-terminal c-Src was ana-
lyzed by cyanogen bromide mapping. The level of phospho-
tyrosine 530, a regulatory site of the kinase activity [19], in
induced RN1 cells was the same as that of uninduced RN1
cells, judging from the ratio of the combined radioactivity of
4 and 6 kDa bands containing phosphotyrosine 530 to that of
a N-terminal 31 kDa band containing phosphoserine 17 (Fig.
4B). This is consistent with no change in the speci¢c activity
of c-Src kinase, which was compared between equal amounts
of c-Src from IPTG-treated and untreated RN1 cells (data not
shown). On the other hand, phosphotyrosine 419 (10 kDa
band) was detected in c-Src only from RN1 cells with IPTG
induction (Fig. 4B). To reveal the phosphorylation pattern of
N-terminal c-Src, we performed 2-dimensional phosphopep-
tide mapping of N-terminal V8-digested 16 kDa fragments
of RN1 c-Src. Phosphoserine 75-containing peptide was de-
tected in c-Src elevated by IPTG induction (Fig. 4C). The
relative intensity of this phosphopeptide [9] in c-Src from
RN1 cells after induction was about 4 times that of cells with-
out induction. In phosphoamino acid analysis (Fig. 4D), RN1
c-Src contained phosphoserine and phosphotyrosine, but not
phosphothreonine, irrespective of IPTG treatment.
4. Discussion
We examined the e¡ects of overexpressed human c-Src on
cell morphology of NIH3T3 cells using an inducible expres-
sion system with a lac operator and a lac repressor. As shown
in Figs. 1^3, RN1 cells induced to express high-level, func-
tional c-Src kinase exhibited a spherical morphology and
failed to grow in a monolayer. The time course of induction
showed that spherical cells appeared at more than 70% of the
maximum expression level of RN1 c-Src. Other cell lines
(RN2-4) induced to express less than about 60% level of the
RN1 c-Src exhibited no spherical morphology. A decrease to
half of the maximum in c-Src level by removal of the inducer
restored the ¢broblastic morphology and cell growth of RN1
cells. The expression level-dependent behavior of c-Src may
re£ect the existence of a c-Src kinase level threshold required
for the cell rounding. Furthermore, changes in the levels of in
vitro c-Src kinase activity after induction are accompanied by
those in phosphotyrosine levels of several cellular proteins.
Herbimycin A, a Src kinase-speci¢c inhibitor, inhibited the
morphological changes in induced RN1 cells, accompanied
by a decrease in the in vitro kinase activity and tyrosine
phosphorylation of cellular proteins. Thus, these results rule
out the possibility that the morphological change was due to a
large amount of the protein, and not to the increased level of
c-Src kinase activity. Overall, we conclude that the highly
elevated level of human c-Src kinase activity can cause spher-
ical cell morphology without loss of anchorage-dependent
growth.
RN1 cells with or without induction expressed proteins that
exhibited the V8-cleavage pattern of normal human c-Src and
not the patterns of activated forms (Fig. 4) such as v-Src [16],
mitotic c-Src [7] or neuronal Src [3]. The absence of phospho-
threonine suggested that induced RN1 cells have no mitotic,
activated c-Src (Fig. 4). Furthermore, cyanogen bromide map-
ping showed that c-Src activation did not occur through Y530
dephosphorylation after induction. Altogether, these results
suggest that the cell rounding in RN1 cells is not ascribed
to gross alteration of the primary structure of c-Src, or not
to c-Src activation.
In contrast, RN1 cells treated with IPTG produced c-Src
phosphorylated additionally on Ser
75
and Tyr
419
compared
with untreated RN1 cells (Fig. 4). Our previous studies
showed that the Ser
75
phosphorylation event correlates with
a spherical morphology in 14 various unsynchronized human
tumor cell lines and in mitotic ¢broblasts and epithelial-like
cells [9]. Thus, Ser
75
phosphorylation may be involved in cell
rounding in RN1 cells. Cdc 2 kinase in vitro phosphorylates
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Fig. 4. Phosphorylation status of RN1 cells with or without IPTG
treatment. A: V8 peptide maps of RN1 c-Src. B: Cyanogen bro-
mide maps of RN1 c-Src. C: Two-dimensional phosphopeptide
maps of RN1 c-Src. D: Phosphoamino acid analysis of RN1 c-Src.
RN1 cells treated or untreated with IPTG for 18 h were labeled
with [
32
P]orthophosphate. c-Src was immunoprecipitated, separated
on SDS-PAGE, and subjected to V8 protease mapping, to cyanogen
bromide cleavage, or to phosphoamino acid analysis. The N-termi-
nal 16 kDa V8 fragments were subjected to 2-dimensional tryptic
phosphopeptide analysis. V1, N-terminal 34 kDa fragments; V2, C-
terminal 26 kDa fragments; V3 and V4, N-terminal 18 kDa and 16
kDa fragments, respectively, derived from further cleavage of V1.
PS, phosphoserine; PY, phosphotyrosine.
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Ser
72
in chicken c-Src corresponding to Ser
75
in human c-Src
[20]. It is possible that the high-level expression of c-Src in
RN1 cells treated with IPTG up-regulates Cdc 2 or other
related kinase(s) and then conversely results in phosphoryla-
tion of Ser
75
in overexpressed c-Src. Tyr419 is an autophos-
phorylation site, which is not stably phosphorylated in c-Src
[21]. High-level expression of c-Src may have stabilized this
phosphorylation. The role of this autophosphorylation has
been elusive [2,22]. Inducible expression of mutant human c-
Src in NIH3T3 cells will reveal the roles of Ser
75
and Tyr
419
phosphorylations in the biological changes of RN1 cells after
induction.
Levels of tyrosine phosphorylations of ¢ve cellular proteins
in RN1 cells changed concomitant with the cell rounding (Fig.
1). These non-identi¢ed, tyrosine-phosphorylated cellular pro-
teins are likely to mediate the morphological change, even if
not all proteins are required. Identi¢cation of these proteins
may also contribute to understanding of the mechanism of cell
rounding in RN1 cells after induction.
Cell spreading and rounding are regulated in normal cellu-
lar activities such as cell division, cellular migration, and mor-
phogenetic processes in epithelial cells and neurons [23]. Sev-
eral lines of evidence suggest that c-Src is involved in the
activities [5,7,24^26]. The spherical RN1 cells retained an an-
chorage dependency on cell growth. In addition, cell mixing
experiments in which either 50, 500, or 5000 RN1 cells were
mixed with 5U10
5
normal NIH3T3 cells [16], resulted in lack
of focus-forming ability, irrespective of IPTG treatment (data
not shown). These data indicated that these cells have proper-
ties distinguishable from those of v-src-transformed NIH3T3
cells, which exhibited anchorage-independent growth potential
and focus-forming ability. Thus, induction of cell rounding
with overexpression of human c-src appeared to be related
to the normal cellular function of c-Src, and not to transform-
ing activity. The cell line conditionally altered in cell morphol-
ogy by regulating the expression of the c-src gene should be
useful to reveal the molecular mechanism for cell rounding by
c-Src, because the overexpressed c-Src a¡ects cell morphology
without a¡ecting anchorage dependence of growth, in con-
trast with v-src transformation.
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